Member Info for Gheko

For me the price action suggests the sorting of a cash raise. So be it. Get on with it company and then the re rate will continue .

I hold a good position and would welcome the raise to fund the exciting developments coming.

‘ We completed a placing and open offer in October 2021. The net proceeds of £6.6m has extended our cash runway at least towards the end of our 2023 financial year using a prudent forecasting basis that excludes all revenues. Material revenues will extend our runway further as we continuously assess our future funding options and requirements. Given the inherent challenges of being first to market in ground-breaking innovative products, compounded by the size and complexity of dealing with the NHS, we will seek additional funding before significant revenue traction is achieved”

So we have a test nearing complete approval in UK by NICE to save babies hearing.

FDA approval next for US which also opens up worldwide market.

Just a thought…..circa 630,000 babies born each year in UK and circa 3.6 MILLION in US alone.

That’s a lot of tests worth a lot of money and then our stroke test. Circa 100,000 strokes each year in UK and circa 800,000 in US. That’s a lot of tests worth a lot of money!!

Cheap as chips

Vlad not going to hanging around. The RNS is coming anytime soon…..

“It is important that we move HEMO-CAR-T into the clinic as quickly as possible and maintain and consolidate our lead in the area of combatting existing and emerging viral infections using our CBR-based product candidates."

https://www.bbc.com/news/health-64570089

Killick must be nearly gone now. As of 3 Feb they had circa 9 million. Selling been incessant since then and today well over a million gone into safe hands.

The bounce is coming imho.

https://www.bbc.com/news/health

Hit the bbc news already. Going to be huge

Given the huge rise in Lucy and huge volume (currently circa 55 million traded) is it possible TEK has sold its stake to an investor at say $4 a pop and a special dividend is to be announced.

Now tha5 would shake things north pronto!

Guy - agree just a gut feeling. We seem to be struggling to push beyond 30p and saw it with Hemo then in came the placing.

As I say not a bad thing as company has huge potential.

Given we had circa £6 million back in March and circa £4 million in October do folks think they will take advantage of recent price strength to top up the coffers?

Not a bad thing of course depending on the price they get it away.

Personally top sliced from buy in at 16p but still holding a nice stake.

Looking at charts next resistance is at 40p. Could easily see that tested this week coming. Very nice chart recovery play.

Bought 100k today around 10.20 but not showing in the numbers.

Something brewing and it will be a very swift re rate as we have seen. Have a good weekend all.

Fact - serious investors were willing to invest at 2.5p a share.

Fact - we moving to clinical trials to solve nasty blood cancers in next couple of months.

Fact - we looking at solving cures for various viruses in one step.

Fact - companies in clinical trials attract huge major pharma investment for companies in ground breaking technology.

So the raise is great business sense. Can’t believe e the negative vibes.

Article in Times today talking about the value in biotech and government recognising the importance of funding for UK pharma. Importantly mentioned need for support to ensure UK pharma not taken out by overseas companies.

HEMO is huge. Now with circa £8 million in cash. No debt. About to enter clinical trials. Plus all the other CBR etc stuff. Wakey wakey market.

Agree Cela. He is the problem with the company coming good. Years of promises etc and nothing. Then the car crash interview so no wonder folk starting to leave in droves.

Going to need to raise money for next drill program as he hasn’t dealt with that. At this rate going to have to be a substantial discount to get a raise away.

Just saying! There was a reason for the last surge just timing wrong. Contracts about to be announced?

It is just relentless. Placing shares be absorbed straightaway. Onwards and upwards

On the news from ZMir

Hemogenyx has taken advantage of its own in house progress, as well as more positive sentiment towards the life sciences space to raise a meaningful amount of cash. Investors will be looking forward to the company now going down the road of monetizing its multi-faceted research.

Just to add to HfH thoughts which I agree with.

Better Hemo raise the cash and be in a strong position as we advance to the exciting phases including clinical rather than a pharma trying to muscle in on the cheap cause we need money.

Lovely getting a 2.5p top up. Onwards and upwards.

Scott - market cap post raise is circa £28.5 million. Still tiny for what will be a clinical company very shortly.

Bit rude Jimbob.

Do you not think the technology is fantastic and therefore for a company with a micro cap of circa £2 million then contracts which were mentioned in the RNS a month ago would transform the share price?

A bounce off ten 20% retrace from recent highs. Good sign it is set to push on up again from here.

Contracts must be close as fantastic technology needed in the Green space for the oil and gas industry.